Relmada Therapeutics
RLMD
RLMD
94 hedge funds and large institutions have $39.6M invested in Relmada Therapeutics in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 35 reducing their positions, and 14 closing their positions.
Holders
94
Holders Change
+4
Holders Change %
+4.44%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
23
Reduced
35
Closed
14
Calls
$271K
Puts
$1.4M
Net Calls
-$1.13M
Net Calls Change
-$1.28M
Top Buyers
Top Sellers
| 1 |
1
BlackRock
New York
|
$1.49M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$318K |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$577K |
| 4 |
4
Walleye Capital
New York
|
$0 |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$3.22M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AB
101
Amalgamated Bank
New York
| – | – | -3,552 | Closed |
|
102
Legal & General Group
London,
United Kingdom
| – | – | -3,074 | Closed |
|
|
AIP
103
Ameritas Investment Partners
Lincoln,
Nebraska
| – | – | -1,926 | Closed |
|
|
BAM
104
Belpointe Asset Management
Reno,
Nevada
| – | – | -1,000 | Closed |
|
|
BWM
105
Baystate Wealth Management
Boston,
Massachusetts
| – | – | -735 | Closed |
|
|
PA
106
Parallel Advisors
San Francisco,
California
| – | – | -582 | Closed |
|
|
CFGS
107
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
FRA
108
Front Row Advisors
Tiburon,
California
| $0 | 6 | – | – |
|
109
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
110
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $0 | 81 | +81 | New |
|